Clinical Trial Update: Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma [NA]

View source ↗

Summary

A clinical trial is evaluating the diagnostic value of a novel PET molecular imaging agent for renal cell carcinoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Novel PET molecular imaging agent (investigational for renal cell carcinoma)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Renal Cell Carcinoma | NA | Status: RECRUITING